ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,965Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 252

$447K Total Retail Price of All Prescriptions

Rank: 115 out of 252

332 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

38% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,213 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 667 396 1 7
HYDROCODONE-ACETAMINOPHEN 646 211 S3 2 5
POTASSIUM CHLORIDE 645 413 3 8
LOVASTATIN 535 341 4 39
MELOXICAM 514 297 5 20
METOPROLOL TARTRATE 401 246 6 10
LEVOTHYROXINE SODIUM 376 276 7 1
OMEPRAZOLE 305 152 8 6
METFORMIN HCL 301 165 9 9
AMLODIPINE BESYLATE 296 193 10 4
SIMVASTATIN 284 183 11 2
LISINOPRIL 248 133 12 3
CLONIDINE HCL 247 115 13 35
NEXIUM 203 57 14 23
TRAMADOL HCL 193 61 15 17
DILTIAZEM HCL 190 99 16 177
WARFARIN SODIUM 183 146 17 14
GLIMEPIRIDE 180 81 18 40
CARISOPRODOL 177 0 R 19 70
GABAPENTIN 174 75 20 11
CARVEDILOL 143 93 21 22
CITALOPRAM HBR 133 79 22 15
RANITIDINE HCL 127 86 23 48
ZOLPIDEM TARTRATE 126 58 24 21
HYDROCHLOROTHIAZIDE 124 94 25 13
METHOCARBAMOL 97 33 R 26 159
ALLOPURINOL 95 59 27 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 51 28 25
DIGOXIN 81 53 29 44
TAMSULOSIN HCL 80 51 30 26
AZITHROMYCIN 77 39 31 37
ATENOLOL 77 34 31 18
METOLAZONE 76 39 33 206
MEGESTROL ACETATE 75 62 R 34 138
NAPROXEN 72 44 35 96
PREDNISONE 71 50 36 42
KLOR-CON M20 70 57 37 69
ACTOS 66 35 38 135
RAMIPRIL 65 54 39 71
AMLODIPINE BESYLATE-BENAZEPRIL 64 41 40 60
FLUOXETINE HCL 63 13 41 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 32 42 87
PROAIR HFA 59 16 43 54
TRAZODONE HCL 59 41 43 31
PREMARIN 59 37 R 43 116
DIOVAN 58 26 46 38
ESCITALOPRAM OXALATE 57 37 47 56
LEVETIRACETAM 57 21 47 131
INSULIN SYRINGE 56 24 49 93
METOPROLOL SUCCINATE 54 39 50 19
IBUPROFEN 54 13 50 130
PRAVASTATIN SODIUM 53 28 52 12
DONEPEZIL HCL 53 53 52 28
ESTRADIOL 53 36 R 52 76
CLOPIDOGREL 53 33 52 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.